Janus Henderson Group’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$290K Hold
20,707
﹤0.01% 2226
2025
Q4
$232K Hold
20,707
﹤0.01% 2303
2025
Q3
$239K Hold
20,707
﹤0.01% 2286
2025
Q2
$253K Hold
20,707
﹤0.01% 2241
2025
Q1
$289K Hold
20,707
﹤0.01% 2220
2024
Q4
$330K Hold
20,707
﹤0.01% 2213
2024
Q3
$497K Hold
20,707
﹤0.01% 2033
2024
Q2
$413K Sell
20,707
-236
-1% -$4.6K ﹤0.01% 2077
2024
Q1
$417K Buy
20,943
+1
+0% +$19 ﹤0.01% 2089
2023
Q4
$470K Sell
20,942
-29
-0.1% -$599 ﹤0.01% 2022
2023
Q3
$424K Sell
20,971
-6
-0% -$136 ﹤0.01% 2013
2023
Q2
$536K Sell
20,977
-26
-0.1% -$685 ﹤0.01% 1938
2023
Q1
$625K Buy
21,003
+11,267
+116% +$327K ﹤0.01% 1891
2022
Q4
$264K Hold
9,736
﹤0.01% 2032
2022
Q3
$212K Buy
9,736
+17
+0.2% +$444 ﹤0.01% 2377
2022
Q2
$266K Sell
9,719
-21
-0.2% -$603 ﹤0.01% 2151
2022
Q1
$326K Buy
9,740
+1
+0% +$32 ﹤0.01% 2170
2021
Q4
$338K Buy
+9,739
New +$315K ﹤0.01% 2137
2020
Q1
Sell
-1,232,198
Closed -$41.5M 1303
2019
Q4
$41.5M Buy
+1,232,198
New +$44.6M 0.02% 650
2015
Q1
Sell
-2,345
Closed -$107K 837
2014
Q4
$107K Buy
+2,345
New +$92.1K ﹤0.01% 841

Other funds holding AVNS

Janus Henderson Group's AVNS Position: Q1 2026 in Review

Janus Henderson Group held its Avanos Medical (AVNS) position steady in Q1 2026 at 20,707 shares worth $290K. The position accounts for ﹤0.01% of the portfolio, ranked #2226.

Janus Henderson Group first reported a position in AVNS in Q4 2014 and has held it in 20 quarters since. The position peaked at $41.5M in Q4 2019. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Janus Henderson Group held 20,707 shares of Avanos Medical worth $290K as of Q1 2026.
  • Janus Henderson Group left its Avanos Medical share count unchanged in Q1 2026.
  • Avanos Medical made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #2226 holding.
  • Janus Henderson Group first reported a position in Avanos Medical in Q4 2014 and has held it in 20 quarters since.
  • Janus Henderson Group's Avanos Medical position peaked at $41.5M in Q4 2019.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.